Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens

Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens

The efficacy of first-line antiretroviral therapy (ART) may be hampered by the presence of HIV drug resistance (HIVDR). We described HIV-1 pre-treatment drug resistance (PDR) patterns, effect of viral clades on PDR, and programmatic implications on first-line regimens in Cameroon. A sentinel surveil...

Full description

Bibliographic Details
Main Authors: Joseph Fokam, Collins Ambe Chenwi, Valère Tala, Désiré Takou, Maria Mercedes Santoro, George Teto, Beatrice Dambaya, Felix Anubodem, Ezechiel Ngoufack Jagni Semengue, Grace Beloumou, Sandrine Djupsa, Edgar Assomo, Charles Fokunang, Claudia Alteri, Serge Billong, Nounouce Pamen Bouba, Rogers Ajeh, Vittorio Colizzi, Dora Mbanya, Francesca Ceccherini-Silberstein, Carlo-Federico Perno, Alexis Ndjolo
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Viruses
Subjects:
pre-treatment drug resistance
HIV-1
genetic diversity
first-line regimens
Cameroon
Online Access:https://www.mdpi.com/1999-4915/15/7/1458

Internet

https://www.mdpi.com/1999-4915/15/7/1458

Similar Items